Distinct effects of testosterone on plasma and cerebrospinal fluid amyloid-β levels

Journal of Alzheimer's Disease

Volumn 15, Issue 1, 2008, Pages 129-137

  Wahjoepramono, Eka J ^a,b   Wijaya, Linda K ^a,b,c   Taddei, Kevin ^a,c   Martins, Georgia ^a,b   Howard, Matthew ^a,c   De Ruyck, Karl ^a,c   Bates, Kristyn ^a,c   Dhaliwal, Satvinder S ^d   Verdile, Giuseppe ^a,c   Carruthers, Malcolm ^e   Martins, Ralph N ^a,c  

^a EDITH COWAN UNIVERSITY   (Australia)

^b PELITA HARAPAN UNIVERSITY   (Indonesia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d CURTIN UNIVERSITY   (Australia)

^e Centre for Mens Health   (United Kingdom)

Author keywords

Aging; Alzheimer's disease; Amyloid ; Castration; Cerebrospinal fluid; Guinea pig; Testosterone

Indexed keywords

AMYLOID BETA PROTEIN; TESTOSTERONE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CASTRATION; CEREBROSPINAL FLUID; CONTROLLED STUDY; GUINEA PIG; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 52449115729     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2008-15111     Document Type: Article

References (27)

1. O.P. Almeida, A. Waterreus, N. Spry, L. Flicker and R.N. Martins, One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men, Psychoneuroendocrinology 29 (2004), 1071-1081.
2. R. Bi, G. Broutman, M.R. Foy, R.F. Thompson and M. Baudry, The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus, Proc Natl Acad Sci USA 97 (2000), 3602-3607.
3. R.L. Bowen, G. Verdile, T. Liu, A.F. Parlow, G. Perry, M.A. Smith, R.N. Martins and C.S. Atwood, Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition, J Biol Che 279 (2004), 20539-20545.
4. R.D. Brinton, Impact of estrogen therapy on Alzheimer's disease: a fork in the road? CNS Drugs 18 (2004), 405-422.
5. M.M. Cherrier, A.M. Matsumoto, J.K. Amory, M. Johnson, S. Craft, E.R. Peskind and M.A. Raskind, Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older men, Psychoneuroendocrinology 32 (2007), 72-79.
6. R. Deane, Z. Wu and B.V. Zlokovic, RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier, Stroke 35 (2004), 2628-2631.
7. S.J. Fuller, E. Storey, Q.X. Li, A.I. Smith, K. Beyreuther and C.L. Masters, Intracellular production of beta A4 amyloid of Alzheimer's disease: modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor protein, Biochemistry 34 (1995), 8091-8098.
8. S.J. Fuller, R.S. Tan and R.N. Martins, Androgens in the etiology of Alzheimer's disease in aging men and possible therapeutic interventions, J Alzheimers Dis 12 (2007), 129-142.
9. S. Gandy, O.P. Almeida, J. Fonte, D. Lim, A. Waterrus, N. Spry, L. Flicker and R.N. Martins Chemical andropause and amyloid-beta peptide, JAMA 285 (2001), 2195-2196.
10. M.I. Geerlings, D. Strozyk, K. Masaki, A.T. Remaley, H. Petrovitch, G.W. Ross, L.R. White and L.J. Launer, Endogenous sex hormones, cognitive decline, and future dementia in old men, Ann Neurol 60 (2006), 346-355.
11. M.J. Gillett, R.N. Martins, R.M. Clarnette, S.A. Chubb, D.G. Bruce and B.B. Yeap, Relationship between testosterone, sex hormone binding globulin and plasma amyloid beta peptide 40 in older men with subjective memory loss or dementia, J Alzheimers Dis 5 (2003), 267-269.
12. S. Goodenough, S. Engert and C. Behl, Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway, Neurosci Lett 296 (2000), 49-52.
13. G.K. Gouras, H. Xu, R.S. Gross, J.P. Greenfield, B. Hai, R. Wang and P. Greengard, Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides, Proc Natl Acad Sci USA 97 (2000), 1202-1205.
14. M.T. Haren, J.E. Morley, I.M. Chapman, P.D. O'Loughlin and G.A.Wittert, Defining 'relative' androgen deficiency in aging men: how should testosterone be measured and what are the relationships between androgen levels and physical, sexual and emotional health? Climacteric 5 (2002), 15-25.
15. E. Hogervorst, S. Bandelow, M. Combrinck and A.D. Smith, Low free testosterone is an independent risk factor for Alzheimer's disease, Exp Gerontol 39 (2004), 1633-1639.
16. E. Hogervorst, M. Combrinck and A.D. Smith, Testosterone and gonadotropin levels in men with dementia, Neuro Endocrinol Lett 24 (2003), 203-208.
17. E. Hone, I.J. Martins, J. Fonte and R.N. Martins, Apolipoprotein E influences amyloid-beta clearance from the murine periphery, J Alzheimers Dis 5 (2003), 1-8.
18. D. Manthey, S. Heck, S. Engert and C. Behl, Estrogen induces a rapid secretion of amyloid beta precursor protein via the mitogen-activated protein kinase pathway, Eur J Biochem 268 (2001), 4285-4291.
19. S.D. Moffat, A.B. Zonderman, E.J. Metter, C. Kawas, M.R. Blackman, S.M. Harman and S.M. Resnick, Free testosterone and risk for Alzheimer disease in older men, Neurology 62 (2004), 188-193.
20. S.S. Petanceska, V. Nagy, D. Frail and S. Gandy, Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain, Neurology 54 (2000), 2212-2217.
21. C.J. Pike, E.R. Rosario and T.V. Nguyen, Androgens, aging, and Alzheimer's disease, Endocrine 29 (2006), 233-241.
22. M. Ramsden, A.C. Nyborg, M.P. Murphy, L. Chang, F.Z. Stanczyk, T.E. Golde and C.J. Pike, Androgens modulate beta-amyloid levels in male rat brain, J Neurochem 87 (2003), 1052-1055.
23. E.R. Rosario, J.C. Carroll, S. Oddo, F.M. LaFerla and C.J. Pike, Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease, J Neurosci 26 (2006), 13384-13389.
24. E.R. Rosario, L. Chang, F.Z. Stanczyk and C.J. Pike, Age-related testosterone depletion and the development of Alzheimer disease, JAMA 292 (2004), 1431-1432.
25. G.D. Silverberg, M. Mayo, T. Saul, E. Rubenstein and D. McGuire, Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis, Lancet Neurol 2 (2003), 506-511.
26. R.S. Swerdloff, C. Wang, G. Cunningham, A. Dobs, A. Iranmanesh, A.M. Matsumoto, P.J. Snyder, T. Weber, J. Longstreth and N. Berman, Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men, J Clin Endocrinol Metab 85 (2000), 4500-4510.
27. R.E. Tanzi and L. Bertram, Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective, Cell 120 (2005), 545-555.